Parallel trade in pharmaceuticals and EC competition law

Apart from patent disputes linked to generic entry, perhaps no issue has spawned more litigation in the European pharmaceutical sector than parallel trade. At the root of the problem are price differences among member states for pharmaceutical products that are caused by national price controls. Against this background, this article examines supply chain management systems, dual pricing systems, direct-to-pharmacy distribution systems and repackaging.

Register for free access

To access this resource and thousands more, register for a free, no-obligation trial of Practical Law. Register using the button below, telephone +44 (0)20 7202 1220 or e-mail info@practicallaw.com.

A free trial will give you:

Unlimited access to Practical Law online know-how
Thousands of market standard documents and clauses
Daily alerts and weekly update e-mails on key legal developments in your practice area
 

Register

Log in

To access this resource, log in below or register for free access.

Contact us

Our customer services team are available every working day 8.30am to 7pm (GMT).

{ "siteName" : "PLC", "objType" : "PLC_Doc_C", "objID" : "1247243521500", "objName" : "Parallel trade in pharmaceuticals and EC competition law", "userID" : "2", "objUrl" : "http://crossborder.practicallaw.com/cs/Satellite/5-383-9423?source=relatedcontent", "pageType" : "", "contentAccessed" : "false", "analyticsPermCookie" : "256c544cf:13ec93f6107:775", "analyticsSessionCookie" : "256c544cf:13ec93f6107:776", "statisticSensorPath" : "http://analytics.practicallaw.com/sensor/statistic" }